Ameritas Investment Partners, Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$9,166
-76.2%
5,7650.0%0.00%
-100.0%
Q4 2022$38,568
+28.6%
5,765
+28.7%
0.00%
+100.0%
Q3 2022$30,000
+7.1%
4,4800.0%0.00%0.0%
Q2 2022$28,000
+33.3%
4,4800.0%0.00%0.0%
Q1 2022$21,000
+90.9%
4,480
+97.1%
0.00%
Q4 2021$11,000
-59.3%
2,2730.0%0.00%
-100.0%
Q3 2021$27,000
-43.8%
2,2730.0%0.00%
-50.0%
Q2 2021$48,000
-25.0%
2,2730.0%0.00%0.0%
Q1 2021$64,000
+8.5%
2,2730.0%0.00%
-33.3%
Q4 2020$59,000
-29.8%
2,2730.0%0.00%
-25.0%
Q3 2020$84,000
-28.2%
2,2730.0%0.00%
-33.3%
Q2 2020$117,000
+62.5%
2,2730.0%0.01%
+50.0%
Q1 2020$72,000
-44.2%
2,273
+4.9%
0.00%
-33.3%
Q4 2019$129,000
+76.7%
2,166
+8.7%
0.01%
+100.0%
Q3 2019$73,000
-21.5%
1,9930.0%0.00%
-25.0%
Q2 2019$93,000
+16.2%
1,9930.0%0.00%0.0%
Q1 2019$80,000
-13.0%
1,9930.0%0.00%
-20.0%
Q4 2018$92,000
+4.5%
1,9930.0%0.01%
+25.0%
Q3 2018$88,000
+12.8%
1,9930.0%0.00%0.0%
Q2 2018$78,000
-25.7%
1,993
+37.9%
0.00%
-20.0%
Q1 2018$105,000
+22.1%
1,445
+10.3%
0.01%
+25.0%
Q4 2017$86,000
+34.4%
1,3100.0%0.00%
+33.3%
Q3 2017$64,000
+4.9%
1,3100.0%0.00%0.0%
Q2 2017$61,000
+69.4%
1,310
+29.3%
0.00%
+50.0%
Q1 2017$36,0001,0130.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders